Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine

Transplant Proc. 1994 Dec;26(6):3202.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Heterophile / biosynthesis*
  • Cricetinae
  • Cyclosporine / therapeutic use*
  • Cytotoxicity, Immunologic / drug effects
  • Drug Therapy, Combination
  • Graft Survival / drug effects*
  • Graft Survival / immunology
  • Heart Transplantation / immunology*
  • Immunosuppression Therapy
  • Immunosuppressive Agents / therapeutic use
  • Isoxazoles / therapeutic use*
  • Leflunomide
  • Male
  • Mesocricetus
  • Rats
  • Rats, Inbred Strains
  • Time Factors
  • Transplantation, Heterologous / immunology*

Substances

  • Antibodies, Heterophile
  • Immunosuppressive Agents
  • Isoxazoles
  • Cyclosporine
  • Leflunomide